Renaissance Technologies’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
Other funds holding BNR
KCM
CL
NAMA
RWMG
HH
Renaissance Technologies's BNR Position: Q1 2026 in Review
Renaissance Technologies increased its Burning Rock Biotech (BNR) stake by 14% in Q1 2026, buying an estimated $112K and bringing the position to 35,407 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #2549.
Renaissance Technologies first reported a position in BNR in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.2M in Q2 2022. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.
- Renaissance Technologies held 35,407 shares of Burning Rock Biotech worth $571K as of Q1 2026.
- Renaissance Technologies bought 4,290 Burning Rock Biotech shares in Q1 2026, an estimated $112K.
- Burning Rock Biotech made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2549 holding.
- Renaissance Technologies first reported a position in Burning Rock Biotech in Q3 2021 and has held it in 19 quarters since.
- Renaissance Technologies's Burning Rock Biotech position peaked at $3.2M in Q2 2022.
- 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.